Researchers have found that more than half of patients who stop taking GLP-1 inhibitors restart within one year, while nearly two-thirds restart within two years
On the role of the peptide galanin in regulation of growth hormone secretion
We focus on small-batch synthesis and rigorous third-party testing to guarantee that the peptide in the vial is exactly what it says it is, at the stated purity and quantity
If prevention fails, holistic and personalized management should be taken as soon as possible through timely detection and diagnosis, considering target organ protection, comorbidities, treatment goals, and other factors in reality
a case report and review of the literature
Patel SP, Sullivan PG, Lyttle TS, Rabchevsky AG